February 22, 2017 / 9:40 PM / in 8 months

BRIEF-Cleveland Biolabs reports Q4 loss per share $0.11

Feb 22 (Reuters) - Cleveland Biolabs Inc

* Cleveland Biolabs reports 2016 financial results and development progress

* Q4 loss per share $0.11

* Q4 revenue $1.0 million versus $1.3 million

* Cleveland Biolabs - as of Dec 31, cash, cash equivalents, short-term investments estimated to fund operations for at least one year beyond filing of form 10-k Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below